After an 80-year gap, human trials of a new tuberculosis vaccine are due to
start. If the vaccine is successful it could save millions of lives each year.
TB jabs use a weakened form of the bacterium that causes the disease in
cows—Bacille Calmette-Guérin. BCG gives good protection for about
10 years but then it wears off, and booster shots have little effect. Now Helen
McShane at the John Radcliffe Hospital in Oxford is starting trials with a
modified cowpox virus that carries a TB antigen. Used as a booster after BCG,
the new vaccine should give a…
To continue reading, today with our introductory offers
Advertisement
More from 91av
Explore the latest news, articles and features
Popular articles
Trending 91av articles
1
Man destined for Alzheimer's may have been saved by accidental therapy
2
Woman in cancer remission without treatment in highly unusual case
3
Extinct relative of koalas discovered in Western Australia
4
We have figured out a new way to send messages into the past
5
Smart underwear detects lactose intolerance by tracking your farts
6
A lost ancient script reveals how writing as we know it really began
7
300-year-old experiment could become world's best dark matter detector
8
Exercise helps fight cancer – and we may finally know why
9
The problem of cosmic inflation and how to solve it
10
Cancer-causing chemical found to be leaking from gas cookers
